Literature DB >> 21971712

Targeting IL-6 promoter polymorphism -174G/C should be dependent on ethnicity.

Wang-Dong Xu, Yu-Jing Zhang, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21971712     DOI： 10.1007/s10067-011-1867-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Medication use in systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Christine Peschken; Paul R Fortin; Christian A Pineau; Christi A Pineau; Murray B Urowitz; Dafna D Gladman; Janet E Pope; Marie Hudson; Michel Zummer; C Douglas Smith; Hector O Arbillaga; Ann E Clarke
Journal:  J Rheumatol       Date:  2010-11-15       Impact factor: 4.666

2.  Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.

Authors:  Esmaeil Moazemi Godarzi; Eskandar Kamali Sarvestani; Elham Aflaki; Zahra Amirghofran
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

3.  Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus.

Authors:  H Schotte; B Schlüter; S Rust; G Assmann; W Domschke; M Gaubitz
Journal:  Rheumatology (Oxford)       Date:  2001-04       Impact factor: 7.580

4.  Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression.

Authors:  M Linker-Israeli; D J Wallace; J Prehn; D Michael; M Honda; K D Taylor; M Paul-Labrador; N Fischel-Ghodsian; P A Fraser; J R Klinenberg
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

5.  Interleukin-6 promoter polymorphism -174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients.

Authors:  Maria José Santos; Diana Fernandes; Susana Capela; Jose Canas da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2010-12-14       Impact factor: 2.980

Review 6.  What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE.

Authors:  H-S Lee; S-C Bae
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

7.  Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.

Authors:  P Guarnizo-Zuccardi; Y Lopez; M Giraldo; N Garcia; L Rodriguez; L Ramirez; O Uribe; L Garcia; G Vasquez
Journal:  Tissue Antigens       Date:  2007-08-17

8.  Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus.

Authors:  K H Chua; B P Kee; S Y Tan; L H Lian
Journal:  Braz J Med Biol Res       Date:  2009-06       Impact factor: 2.590

9.  HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus.

Authors:  Antoni Hrycek; Urszula Siekiera; Paweł Cieślik; Witold Szkróbka
Journal:  Rheumatol Int       Date:  2004-09-21       Impact factor: 2.631

10.  Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

Authors:  David Isenberg; Gerald B Appel; Gabriel Contreras; Mary A Dooley; Ellen M Ginzler; David Jayne; Jorge Sánchez-Guerrero; David Wofsy; Xueqing Yu; Neil Solomons
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.